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Abstract
Enzymes are typically highly stereoselective catalysts that enforce a reactive conformation on 
their native substrates. We report here a rare example where the substrate controls the 
stereoselectivity of an enzyme-catalyzed Michael-type addition during the biosynthesis of 
lanthipeptides. These natural products contain thioether crosslinks formed by cysteine attack on 
dehydrated Ser and Thr residues. We demonstrate that several lanthionine synthetases catalyze 
highly selective anti additions in which the substrate (and not the enzyme) determines whether the 
addition occurs from the Re or Si face. A single point mutation in the peptide substrate completely 
inverted the stereochemical outcome of the enzymatic modification. Quantum mechanical 
calculations reproduced the experimentally observed selectivity and suggest that conformational 
restraints imposed by the amino acid sequence on the transition states determine the face 
selectivity of the Michael-type cyclization.
The stereochemical outcome of chemical reactions between chiral molecules in which one 
or more new stereocenters are generated is often governed by the stereochemistry of the 
substrate or reagent, resulting in substrate or reagent controlled processes1. For enzymatic 
reactions, the well-organized chiral environment of the enzyme active site typically results 
in reagent control for physiological processes. In this study, we discovered a rare case where 
the substrate controls the stereochemical outcome of an enzyme-catalyzed Michael-type 
addition during the biosynthesis of lanthipeptides.
Lanthipeptides are a large family of ribosomally synthesized and post-translationally 
modified peptides (RiPPs), which constitute a growing class of natural products2. Their 
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precursor peptides (called LanAs) consist of an N-terminal leader peptide that is essential for 
recognition by the enzymes that carry out the post-translational modifications3 (Fig. 1a). The 
latter take place in the C-terminal core region of the precursor peptide, and involve 
dehydration of serine and threonine residues to generate dehydroalanine (Dha) and 
dehydrobutyrine (Dhb), respectively (Fig. 1a and 1b). Subsequently, the thiols from cysteine 
residues are added to the newly formed double bonds in Dha and Dhb via a Michael-type 
addition. The resulting thioether bridges are termed lanthionine (Lan) and methyllanthionine 
(MeLan), respectively (Fig. 1b). In class II lanthipeptides, both the dehydration and 
cyclization reactions are catalyzed by one bi-functional enzyme that is generically termed 
LanM (e.g. CylM in Fig. 1a)4,5. Many lanthipeptides display antimicrobial activity and are 
designated lantibiotics6, with some members potently inhibiting the growth of a broad range 
of pathogens7.
Lanthipeptides have been extensively studied over the past 30 years, with structural 
information available for a subset of compounds8. Until recently, it was generally assumed 
that the cysteine addition always gave (2S, 6R)-Lan (hereafter called DL-Lan) and (2S, 3S, 
6R)-MeLan (hereafter DL-MeLan) (Fig. 1b). This assumption was recently challenged by 
the discovery of (2R, 3R, 6R)-MeLan (LL-MeLan, Fig. 1b) in two class II lantibiotics - the 
cytolysin from Enterococcus faecalis and haloduracin produced by Bacillus halodurans9. 
The enterococcal cytolysin consists of two peptides called cytolysin L (CylLL”, Figure 1c) 
and cytolysin S (CylLS”, Figure 1a), which are generated from the precursor peptides CylLL 
and CylLS, respectively, by a single lanthionine synthetase CylM. The production of 
cytolysin enhances virulence in infection models of E. faecalis and is associated with acute 
patient mortality10–13. Haloduracin is an antimicrobial substance that also consists of two 
peptides (Fig. 1c)14. Based on sequence homology of the rings containing the LL-MeLan 
residues in cytolysin and haloduracin, we have suggested that a Dhb-Dhb-Xxx-Xxx-Cys 
motif (Xxx represents amino acids other than Dha, Dhb and Cys) (Fig. 1) induces the 
formation of the unusual MeLan stereochemistry9. In this model, the LL stereochemistry is 
formed by anti-addition of cysteine to the Re face of the alkene because of a conformational 
preference of the substrate that is unique to this motif9.
These findings have raised a number of intriguing questions. First, given that cytolysin and 
haloduracin contain both LL- and DL-(Me)Lan, how can one enzyme catalyze similar 
conjugate additions with different stereochemistries in a single polypeptide substrate? 
Second, does the substrate sequence indeed govern the diastereoselectivity? And third, is it 
possible to manipulate the stereochemical outcome by mutating the peptide substrate? In this 
study, we show that the formation of LL-MeLan from the Dhb-Dhb-Xxx-Xxx-Cys sequence 
is not specific to the enzymes involved in cytolysin or haloduracin biosynthesis. 
Furthermore, we demonstrate that a Dhb-to-Ala mutation at the second position of the motif 
results in MeLan formation with the canonical DL stereochemistry, supporting the substrate 
control hypothesis. Quantum mechanical simulations of dehydrated peptides confirm an 
intrinsic preference for Re face or Si face addition depending on the sequence of the 
substrate peptide.
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Results
Generality of LL-MeLan formation from Dhb-Dhb-Xxx-Xxx-Cys
To test the hypothesis that the substrate peptide sequence containing the Dhb-Dhb-Xxx-
Xxx-Cys motif determines the formation of LL stereochemistry independent of the identity 
of the lanthionine synthetase, we generated chimeric peptides with the CylLS core peptide 
connected to leader peptides from different class II lanthipeptides. These leader peptides 
were expected to be recognized by their cognate lanthionine synthetases that carry out the 
dehydration and cyclization reactions in the core peptide (Fig. 2a). The gene halA2-cylLS 
that encodes a chimeric peptide consisting of the leader peptide of the haloduracin β (Halβ) 
precursor peptide (HalA2) fused to the CylLS core peptide (Fig. 2a) was co-expressed in E. 
coli with halM2 encoding the Halβ synthetase HalM215. Modified HalA2-CylLS was 
purified and analysis by matrix-assisted laser desorption ionization time-of-flight (MALDI-
TOF) mass spectrometry (MS) showed the desired four dehydrations (Supplementary 
Results, Supplementary Fig. S1). The modified chimeric peptide was hydrolyzed in 6 M 
HCl to individual amino acid residues, which were derivatized and analyzed by gas 
chromatography (GC) MS using a chiral GC column to reveal the stereochemistry of the 
(Me)Lan residues9,16. Signals corresponding to LL-MeLan and DL-Lan were observed as 
the predominant products by comparison with synthetic standards derivatized in the same 
way (Fig. 2b, 2c; Table 1 and Supplementary Fig. S2). Hence, HalM2 catalyzes the 
cyclization of the CylLS core peptide with the same stereochemical selectivity as CylM. 
This result was perhaps not too surprising since HalM2 converts a Dhb-Dhb-Trp-Pro-Cys 
sequence into an LL-MeLan cross-link in its native substrate HalA2 (Fig. 1c)9. We therefore 
turned to LanM enzymes that only form DL-(Me)Lan in their natural substrates. The 
lanthionine synthetase LtnM2 involved in the biosynthesis of the lantibiotic lacticin 3147 
A217 was evaluated next. An LtnA2-CylLS peptide consisting of the leader peptide from the 
natural LtnM2 substrate (LtnA2) and the core peptide from CylLS was co-expressed with 
LtnM2 in E. coli. MALDI-TOF MS analysis illustrated the desired four dehydrations 
(Supplementary Fig. S3). Hydrolysis and derivatization of the modified LtnA2-CylLS 
peptide once again resulted in almost exclusive LL-MeLan and DL-Lan signals in GC-MS 
experiments (Fig. 2b, 2c; Table 1 and Supplementary Fig. S4), demonstrating that LtnM2 
also preferentially forms the LL stereochemistry when guided by the substrate sequence. We 
then chose ProcM as our next LanM target. ProcM is a lanthionine synthetase with 29 
natural substrates (ProcAs) that exhibits high substrate tolerance18. ProcM can generate 
many different ring topologies, and based on the currently structurally characterized ProcA 
products, they all have the DL-(Me)Lan stereochemistry (Supplementary Fig. S5)19. It has 
been suggested that it is the sequence of the ProcA peptides, rather than the ProcM enzyme, 
that primarily determines the cyclization patterns20. As such, ProcM would be the perfect 
candidate to test the hypothesis that the unusual LL-MeLan stereochemistry produced from 
the Dhb-Dhb-Xxx-Xxx-Cys motif is determined by the substrate. In this study, the ProcA3.2 
leader peptide was chosen for a chimeric ProcA3.2-CylLS peptide and the latter was co-
expressed with ProcM in E. coli. The modified ProcA3.2-CylLS peptide afforded several 
products that differed in the extent of dehydration with 2- and 4-fold dehydrated peptides as 
the major products (Supplementary Fig. S6). The modified peptides were hydrolyzed, and 
the resulting amino acids were derivatized and subjected to GC-MS analysis. In this case, 
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we observed an LL-MeLan peak with a relatively low intensity as well as a DL-Lan signal 
(Fig. 2b, 2c; Table 1 and Supplementary Fig. S7). The low signal intensity of the derivatized 
MeLan compared with Lan could be the result of the observed incomplete dehydration of 
the non-cognate core peptide or because of partial cyclization by ProcM. Regardless, the 
MeLan that was generated clearly was formed with high selectivity for the LL 
stereochemistry. Collectively, these results demonstrate that class II LanM enzymes have a 
general preference for converting sequences containing the Dhb-Dhb-Xxx-Xxx-Cys motif 
into LL-MeLan (Table 1).
Mutation of the Dhb-Dhb-Xxx-Xxx-Cys motif
To probe whether the two consecutive dehydro amino acids in the motif impart formation of 
the LL stereochemistry, Thr2 in HalA2 was mutated to Ala. The HalA2-T2A peptide was 
co-expressed with its synthetase HalM2 in E. coli, resulting in the desired elimination of six 
water molecules. After leader peptide removal via an engineered Factor Xa cleavage site15, 
the modified HalA2-T2A core peptide was subjected to tandem MS (MS/MS) analysis, 
which confirmed the formation of the expected ring pattern (Fig. 3a). The modified peptide 
was then hydrolyzed, and the resulting amino acids were derivatized and analyzed by GC-
MS. A DL-MeLan signal was almost exclusively observed, compared with a 2:1 ratio of 
DL:LL MeLan signals observed for the wild-type HalA2 peptide after HalM2 modification 
(the LL-MeLan residue originating from the A ring and two DL-MeLan residues originating 
from the C and D rings) (Fig. 3b, Table 1 and Supplementary Fig. S8)9; as expected the DL-
configuration of the Lan residue (ring B) remained unchanged in the mutant (Supplementary 
Fig. S8). To rule out the possibility that the A ring of the HalA2-T2A mutant was not 
properly cyclized, which would mean that the observed DL-MeLan signal originated solely 
from the C and D rings, we used trypsin to remove the leader peptide and analyzed the core 
peptide mass with liquid chromatography MS (LC-MS). If the A ring of the HalA2-T2A 
mutant was not properly cyclized, the core peptide would start with a Dhb, which would 
hydrolyze to a ketone after the removal of the leader peptide, giving a mass increase of 1 
Da14. We chose trypsin over Factor Xa because trypsin exhibits minimal bias in terms of 
digestion efficiency when the cleavage site is located next to a dehydrated amino acid21. The 
observed mass for the HalA2-T2A core peptide was 2318.0476 Da (Fig. 3c), in agreement 
with the calculated mass of the cyclized peptide (2318.0469 Da). We did not observe any 
peak in the LC trace with a mass corresponding to the non-cyclized peptide (calculated 
2319.0309 Da). Collectively, these results show that the A ring of the HalA2-T2A mutant 
was successfully cyclized and had the DL stereochemistry, strongly suggesting that the 2nd 
Dhb in the Dhb-Dhb-Trp-Pro-Cys sequence is critical for the formation of LL-MeLan by 
HalM2. By mutation of the 2nd Dhb to Ala, the stereochemistry of the MeLan residue in the 
A ring of HalA2 could be successfully changed from LL to DL.
Computational studies on the inherent cyclization stereoselectivity
Computational simulations have been successfully applied previously to correlate inherent 
substrate reactivity with observed enzymatic selectivities22,23. To investigate the possible 
origins of the experimentally observed sequence-dependent stereochemical preferences in 
this work, the cyclization reactions were studied computationally for the A rings of the 
CylLS and HalA2 core peptides. The high flexibility of the substrates confers the stereo-
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determining transition structures (TS) a potentially vast conformational diversity; therefore, 
a multilevel approach combining molecular dynamics (MD) and quantum mechanical (QM) 
calculations of optimized TS was employed to locate the minimum energy pathways for 
both Re and Si face additions for each model peptide.
The CylLS sequence leading to its A ring was very rigid in the MD simulations (Fig. 4a) as 
depicted by the Ramachandran plots of the residues involved in the macrocyclization (Fig. 
4b–f). In the experimentally favored Re-face approach, the Dhb-Dhb and Pro-Ala sequences 
act synergistically to generate a stable secondary structure with characteristics of both α-
helix (i+4→i hydrogen bonding) and 310-helix (i+3→i hydrogen bonding), as previously 
found for peptides containing α,β-dehydro amino acids24,25. The majority of the Cys 
population (64%) was also found in a helix-like secondary structure, whereas the non-
reactive Dhb attained a distorted γ-turn-like arrangement in which the α,β-unsaturated 
carbonyl system deviates from planarity due to hydrogen bonding interactions and the 
influence of the neighboring proline. Well-defined hydrogen bonds between the carbonyl of 
the reactive Dhb and the amide hydrogens of Ala (i+3) and Cys (i+4) were observed along 
the entire MD trajectory. Additional hydrogen bonds between the carbonyl of the adjacent 
Dhb (i+1) and the amide hydrogens of Ala and Cys further stabilize this tightly folded motif. 
In contrast, the secondary structure of the CylLS A-ring sequence for Si face approach is 
more flexible. In order for the nucleophilic cysteine to approach the Si face of the alkene, the 
reactive Dhb changes from an α-helical (s-cis) to a PPII (s-trans) conformation (the latter 
having two mirror image populations, Figure 4b), forced by the rigidity of the proline 
backbone. This proline is in α-helix and PPII conformations in a 70:30 ratio, and the 
adjacent Dhb is also flexible, showing two main populations with γ-turn (distorted s-trans, 
72%) or αL-helix-like (distorted s-cis, 23%) conformations. The four hydrogen bonds 
described above are frequently disrupted, which correlates with transitions between the 
described conformations (Supplementary Fig. S9). Overall, this higher flexibility and the 
disruption of the tight hydrogen bond network suggest that the Si face approach might be 
disfavored for the Dhb-Dhb-Pro-Ala-Cys sequence.
These preliminary observations were confirmed by the large difference in the activation 
barriers (ΔΔG‡) calculated for the Michael-type additions to the Re and Si faces of Dhb, 
which favors the diastereoselective formation of LL-MeLan by 3.2 kcal mol−1 (>99:1 d.r. at 
25 °C, Supplementary Table 2), in agreement with our experimental observations (Table 1 
and Fig. 5). This preference for the Re face approach is rationalized in terms of the ability of 
the substrate to form a rigid oxyanion hole in this orientation (Fig. 5), allowing efficient 
stabilization of the incipient negative charge on the carbonyl oxygen by two amide 
hydrogens. Of note, the backbone amides stabilize the enolate sufficiently to make the 
nucleophilic attack slightly exergonic, which is not the normal trend for thio-Michael 
additions in solution26. Additionally, in the favored Re face approach, the enamide is in the 
more reactive s-cis conformation, which may further stabilize the corresponding TS 
compared to that of the Si face approach, in which the enamide is in a less reactive s-trans 
conformation26.
The shift of the proline from the i+2 to the i+3 position with respect to the reacting Dhb, as 
found in the HalA2 sequence (Dhb-Dhb-Trp-Pro-Cys), completely changes the secondary 
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structure in both reactive trajectories (Supplementary Fig. S10). In the Re face approach, the 
reacting Dhb still exhibits an α-helical conformation (planar s-cis), but the non-reacting Dhb 
and Pro adopt mainly an inverse PPII conformation (planar s-trans) due to the release of 
conformational constraints imposed in CylLS by the neighboring proline and the hydrogen 
bond network. The ability to attain a 310-helix is seriously hampered by the impossibility to 
establish i+3→i hydrogen bonds with the reacting Dhb, and therefore the intricate hydrogen 
bond pattern described above for the CylLS sequence is lost. The secondary structure for the 
Si face approach is similar, with no persistent hydrogen bonds along the simulation. Unlike 
in CylLS, the approach of the cysteine to the Si face of Dhb in HalA2 is achieved by 
maintaining the reactive Dhb in an α-helical type conformation and isomerizing the 
neighboring Dhb from a PPII (s-trans) to an α-helical (s-cis) conformation. However, the 
most stable TS for the Michael-type addition differ from those sampled preferentially in the 
restrained MD for the neutral cysteine (Supplementary Fig. S11). Notably, the lowest energy 
conformations of the two Dhb residues in the TS are completely reversed from those 
calculated for the CylLS sequence: s-trans for the reacting Dhb and s-cis for the adjacent 
Dhb in the Re face approach, and s-cis for both Dhb residues in the Si face approach. 
Nevertheless, very high stereoselectivity (96:4, see Supplementary Table 2) towards LL-
MeLan formation was calculated for this sequence based upon the transition state energies, 
in agreement with the experiments. It should be noted that the HalA2 sequence does not 
allow the formation of the tight oxyanion hole observed for CylLS. Consequently, the thio-
Michael addition shows the normal endergonic behavior yielding a higher energy enolate, 
with the overall transformation becoming favored only upon protonation. Interestingly, the 
HalA2 sequence confers the necessary conformational bias to override the suggested less 
reactive character of the s-trans enamide for the favored Re approach26.
With the intrinsic preference for the Re face addition established in the A rings of both 
cytolysin S and Halβ, we next investigated the reversal of stereochemistry in the HalA2-T2A 
mutant. The secondary structure of the A-ring sequence of the mutant is quite similar to that 
of HalA2 (Supplementary Fig. S10 & S12), but the mutation has a deep impact on the 
calculated stereoselectivity, favoring the Si face approach by 2 kcal mol−1 in line with the 
experimental observations. Intriguingly, the geometries of the lowest energy TS calculated 
for this sequence are virtually identical to those of the wild-type sequence, but the 
stereoselectivity is reversed (Table 1 and Supplementary Fig. S13). The presence of an sp3-
hybridized alpha carbon in the Ala instead of the planar arrangement in Dhb perturbs the 
peptide backbone very slightly, but enough to alter the electrostatic environment of the 
reacting fragments. This change is reflected in the molecular dipole moments (µ) calculated 
for the lowest energy TS; whereas in HalA2, the TS for Re face approach is slightly more 
polar (µ = 12.6 D) than for the Si face approach (µ = 11.6 D), for HalA2-T2A both TS are 
equally polar (µ = 13.7 D and 13.6 D for Re and Si face approaches, respectively). In the 
absence of the strong structural driving forces observed for CylLS, more polar TS will be 
preferentially stabilized in moderately polar environments such as the continuum solvent 
used in the calculations and as found in protein active sites, and this is indeed observed for 
HalA2. However, when both TS are equally polar as in HalA2-T2A, the intrinsically more 
reactive character of the enamide s-cis conformation in the Si face approach appears to result 
in reversal of the stereoselectivity with respect to HalA2. Overall, these striking results 
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reflect the complexity of the factors that govern the facial selectivity in the biosynthesis of 
lanthipeptides, since dissimilar sequences with significantly different three-dimensional 
arrangements can provide the same stereoselectivity, but a very subtle change in the 
sequence with almost no geometric effect completely reverts the face selectivity. These 
stereodetermining structural preferences were calculated to be intrinsic to the oligopeptide 
sequences consistent with the observation that the stereochemical outcome is independent of 
the lanthionine synthetases used.
Discussion
The discovery of LL-MeLan residues in the enterococcal cytolysin and haloduracin formed 
from a conserved Dhb-Dhb-Xxx-Xxx-Cys substrate motif revealed the first examples of 
enzymatic formation of non-canonical stereochemistry of MeLan residues. Very recently, 
LL stereochemistry was also reported for the lantibiotic carnolysin that also contains this 
motif27. We show in this work that the unusual stereochemistry is inherent to this sequence 
motif, because four different class II lanthionine synthetases with low sequence identities in 
their cyclase domains (<25% identity) all converted this motif to LL-MeLan products even 
though the enzymes install other rings in the same peptide with DL stereochemistry. Indeed, 
two of the tested lanthionine synthetases only give products with DL stereochemistry in their 
natural substrates, making it highly unlikely that they would have evolved features that favor 
LL-MeLan-containing products. Furthermore, the stereoselectivity was changed from LL to 
DL when the second Dhb in such a motif in HalA2 was mutated to Ala. Thus, these 
Michael-type additions are rare examples of natural enzymatic processes in which 
stereochemistry is substrate-controlled; we have not been able to find other such examples, 
but a related observation has been made in ketoreduction by iterative polyketides synthases 
where substrate length controlled the face selectivity of hydride transfer28. Of course, 
reversal of stereoselectivity of enzymatic reactions has been observed routinely with non-
natural substrate analogs or mutant enzymes29–32.
The computational studies also support a model in which the observed stereochemistry is 
determined to a large extent by the sequence of the substrate peptide, even though the 
transition state structures can differ substantially depending on the location of a Pro residue. 
We suggest that for the formation of most (Me)Lan residues in lanthipeptides, the enzyme 
controls the face selectivity of attack and protonation, resulting in the predominantly 
observed DL stereochemistry. However, we hypothesize that two consecutive Dhb residues 
in the Dhb-Dhb-Xxx-Xxx-Cys motif result in a conformational preference that is 
unfavorable for the canonical interaction with the enzyme active site. The enzyme is likely 
to still activate the Cys residue given the very slow rates of non-enzymatic (Me)Lan 
formation33, but the face selectivity of attack is now governed by the substrate and not the 
enzyme. The role of the enzyme might be investigated in more detail if the cyclization 
reaction could be decoupled from the dehydration reaction such that the non-enzymatic 
reaction could be studied in isolation. Structural information of substrate bound to the 
enzyme will be required to determine whether all calculated transition states can be attained 
in the context of the protein; at present no structures of LanM enzymes are available.
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Methods
General methods
All polymerase chain reactions (PCR) were carried out on a C1000™ thermal cycler (Bio-
Rad). DNA sequencing was performed by ACGT, Inc. MALDI-TOF MS was carried out on 
a Bruker Daltonics UltrafleXtreme MALDI TOF/TOF instrument (Bruker). LC-ESI-Q/TOF 
MS and MS/MS analyses were conducted using a Synapt G1 instrument with an Acquity 
UPLC system (Waters), which was equipped with a Jupiter Proteo C12 column (5 µm; 90 Å; 
100 × 1.0 mm) (Phenomenex). GC-MS analysis was performed in the Mass Spectrometry 
Laboratory (School of Chemical Sciences, UIUC) on an Agilent 7890 gas chromatograph 
(Agilent) with a CP-Chirasil-L-Val fused silica column (25 m × 0.25 mm × 0.15 µm) 
(Agilent). Solid phase extraction was performed with Strata-X polymeric reverse phase 
columns (Phenomenex).
Materials
All oligonucleotides were obtained from Integrated DNA Technologies and used as 
received. Restriction endonucleases, DNA polymerases, and T4 DNA ligase were purchased 
from New England Biolabs. Media components were obtained from Difco Laboratories. 
Trypsin was purchased from Worthington Biochemical Corporation; Factor Xa was obtained 
from New England Biolabs and other endoproteinases were ordered from Roche 
Biosciences.
Strains and plasmids
E. coli DH5α and E. coli BL21 (DE3) cells were used as host for cloning and plasmid 
propagation, and host for protein expression, respectively. Co-expression vector 
pRSFDuet-1 was obtained from Novagen.
Construction of plasmids and expression of peptides
See the method section in the Supplementary Information.
GC-MS analysis
The synthesis of Lan and MeLan standards and the preparation of samples for GC-MS 
analysis were carried out following a reported procedure published elsewhere16,19. The 
modified full length peptides with their leader peptides attached were hydrolyzed and the 
resulting solutions were dried and directly used for derivatization. The derivatized samples 
were analyzed by GC-MS using an Agilent 7890 gas chromatograph equipped with a CP-
Chirasil-L-Val fused silica column (25 m × 0.25 mm × 0.15 µm). Samples were dissolved in 
methanol and introduced to the instrument via a split (1:20) injection at a flow rate of 1.7 
mL/min helium gas. The temperature method used was 160 °C for 2 min, 160 °C to 180 °C 
at 3 °C/min, and 180 °C for 2 min. The selected-ion monitoring (SIM) was achieved by 
extracting the total ion spectra for peaks containing the characteristic fragment masses of 
365 Da for Lan and 379 Da for MeLan residues.
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Protease cleavage of the leader peptides
Modified HalA2-CylLS, ProcA3.2-CylLS and HalA2-T2A peptides were dissolved in H2O 
to a concentration of 3 mg/mL. To a total 200 µL reaction with a final peptide concentration 
of 200 µM, 20 µL of 500 mM HEPES buffer (pH 7.5) was added, followed by 10 µL of 0.02 
mg/mL AspN protease (for HalA2-CylLS), 1 mg/mL GluC protease (for ProcA3.2-CylLS), 
and 1 mg/mL Factor Xa or 5 mg/mL trypsin (for HalA2-T2A). The protease cleavage 
reactions were incubated at 25 °C for 6 to 16 h.
LC-ESI-Q/TOF MS and MS/MS analysis
LC-ESI-Q/TOF MS and MS/MS analysis were performed on a Waters Synapt G1 mass 
spectrometer. For detailed instrument settings, experimental conditions, and data analysis, 
see the method section in the Supplementary Information.
MD simulations
Constrained MD simulations in water were performed using the AMBER 12 package (Case, 
D. A. et al., UCSF, 2012). Parameters for non-natural dehydro amino acids were generated 
using the general AMBER force field (gaff)35, with partial charges set to fit the electrostatic 
potential generated at the HF/6-31G(d) level by the RESP model36. Water molecules were 
treated with the SHAKE algorithm. Long-range electrostatic effects were modeled using the 
particle-mesh-Ewald method37. An 8 Å cutoff was applied to Lennard-Jones and 
electrostatic interactions. The Langevin equilibration scheme was used to control and 
equalize the temperature with a 2 fs time step at a constant pressure of 1 atm and 
temperature of 300 K. Production trajectories were run for 100 ns using McCammon’s 
accelerated MD (aMD) algorithm38,39.
DFT calculations
All calculations were carried out with the Gaussian 09 package (Frisch, M. J. et al., 
Gaussian, Inc., 2009). Full geometry optimizations and transition state searches were carried 
out with the ω-B97X-D range-separated hybrid functional40 and 6-31G(d) basis set. 
Frequency analyses were carried out at the same level used in the geometry optimizations. 
Single point energies were calculated with the M06-2X hybrid functional41 on the optimized 
geometries. Bulk electrostatic effects were considered implicitly during optimization and 
energy evaluation through the IEF-PCM polarizable continuum model42. Cartesian 
coordinates, electronic energies, entropies, enthalpies, Gibbs free energies and lowest 
frequencies of the low energy conformations are available in Supplementary Table 2. For 
details of the computational studies, see the method section in the Supplementary 
Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Biosynthesis of class II lanthipeptides
(a) Generic pathway of class II lanthipeptide biosynthesis with cytolysin S as an example. 
The CylLS peptide is synthesized by the ribosome as a linear precursor peptide with an N-
terminal leader peptide and a C-terminal core peptide. The dehydration of Ser and Thr 
residues to Dha and Dhb residues as well as the Michael-type addition by Cys residues onto 
these α,β-unsaturated amino acids is catalyzed by the bi-functional lanthionine synthetase 
CylM. The leader peptide is then removed by the proteases CylB and CylA, affording 
mature cytolysin S. (b) Dehydration and cyclization reactions catalyzed by LanM enzymes 
that result in (Me)Lan residues with the canonical DL (i.e. D configuration at the α carbon 
originating from Ser or Thr and L configuration at the α carbon of the former Cys) and 
unusual LL (L configuration for both α carbons) stereochemistries. (c) The structures of 
haloduracin (Halα and Halβ) and cytolysin L. Abu, α-aminobutyric acid.
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Figure 2. GC-MS analysis of in vivo modified HalA2-CylLS, LtnA2-CylLS and ProcA3.2-CylLS 
chimeric peptides
(a) HalA2-CylLS, LtnA2-CylLS and ProcA3.2-CylLS chimeras that were modified in E. coli 
by the lanthionine synthetases HalM2, LtnM2, and ProcM, respectively. A generic protein 
structure is shown for the three enzymes. GC-MS traces are shown for hydrolyzed and 
derivatized MeLan residues (b) and Lan residues (c) from modified HalA2-CylLS (blue), 
LtnA2-CylLS (red), and ProcA3.2-CylLS (magenta). All intensities were normalized with 
respect to the predominant product. For co-injection traces with synthetic (Me)Lan 
standards, see Supplementary Fig. S2, S4 and S7.
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Figure 3. Structural characterization of HalM2-modified HalA2-T2A peptide
(a) MS/MS analysis of the HalA2-T2A core peptide modified by HalM2 in E. coli. 
Fragmentation is suppressed in the sequences spanning residues 1–5, 11–15, 17–20 and 21–
24 as a result of ring formation. The b3 ion is attributed to in-ring fragmentation, which is 
rare but has also been observed for cytolysin, nisin and geobacillin9,15,34. (b) GC-MS traces 
for hydrolyzed and derivatized MeLan residues from HalM2-modified HalA2 peptide (blue) 
and HalM2-modified HalA2-T2A peptide (red). For co-injection traces of hydrolyzed and 
derivatized (Me)Lan residues obtained from modified HalA2-T2A peptide with synthetic 
(Me)Lan standards, see Supplementary Fig. S8. (c) Electrospray ionization (ESI) quadrupole 
TOF mass spectrum for modified HalA2-T2A core peptide. The [M+2H]2+ ion was 
observed with an m/z value of 1160.0316 (calculated m/z of cyclized HalA2-T2A core 
peptide with 2 protons: 1160.0313).
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Figure 4. Secondary structure of the A ring of the CylLS core sequence derived from MD 
simulations
(a) Overlay of 20 representative conformers obtained from the accelerated MD (aMD) 
trajectory restrained to the Re face approach. (b–f) Ramachandran plots obtained through the 
simulations for the five residues involved in the macrocyclization. The lowest energy QM 
optimized transition structures for both approximations are shown as blue squares (Re) and 
red circles (Si). The higher rigidity of the peptide backbone in the most stable Re face 
approach is apparent. Also, MD simulations show a change in the conformation of the 
reactive Dhb from α-helical (s-cis) to PPII (s-trans) in the Si face approach, while the 
remaining amino acids qualitatively preserve the same conformation.
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Figure 5. Lowest energy quantum mechanical transition structures for the Re and Si face 
Michael-type additions that generate the A ring in the CylLS core sequence
Geometries were optimized at the IEF-PCM/ω-B97X-D/6-31G(d) level and the relative 
activation free energies (ΔΔG‡, in kcal mol−1) were calculated at the IEF-PCM/M06-2X/
6-311+G(2d,p) level. The depicted kinetic diastereomeric percentage was derived from these 
relative activation energies. The presence of a tight hydrogen bond network in the Re face 
approach, which creates a rigid oxyanion hole to stabilize the developing negative charge on 
the carbonyl oxygen, stabilizes this transition state significantly and favors Re-face attack to 
occur almost exclusively.
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Table 1
Stereochemical outcome of lanthipeptide precursor peptides modified by different lanthionine synthetases.
Peptide
substrate
Lanthionine
synthetase
Configuration of (Me)Lan residue Quantum mechanical
prediction for A ring
A ringa Other rings
CylLS CylMb LL DL LL
HalA2-CylLS HalM2 LL DL LL
LtnA2-CylLS LtnM2 LL DL LL
ProcA3.2-CylLS ProcM LL DL LL
HalA2 HalM2b LL DL LL
HalA2-T2A HalM2 DL DL DL
a
The ring that contains the Dhb-Dhb-Xxx-Xxx-Cys motif.
b
Reported previously9.
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